REG - MD Medical Group - RESULTS OF THE AGM OF SHAREHOLDERS

MD Medical InvestmentsAnnouncement

23/04/2021 08:00

RNS Number : 4188W
  
MD Medical Group Investments PLC
  
23 April 2021
  
 

 
 
 
 
RESULTS OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS
23 April 2021, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, today announces that the Company held its Annual General Meeting of shareholders ("AGM").
The AGM was held at MD Group Clinical Hospital, Sevastopolsky prospect, 24, building 1, Moscow on April 22, 2021 at 10.00 а.m. local time, and had a 100% quorum with 75,125,010 shares present.
The AGM passed the following resolutions by a majority of members:
·      To adopt the consolidated financial statements of the Company for the financial year ended December 31, 2020 together with the reports of directors and independent auditors;
·      To re-appoint KPMG Limited as auditors of the Company to hold office until the conclusion of the next annual general meeting of the Company and the Board of Directors be and is hereby authorized to determine the remuneration of the auditors;
·      To appoint Mr. Simon Rowlands as senior independent non-executive director of the Company with an annual remuneration of RUR 5 825 000 plus taxes, contributions, fees and overhead to hold such office until the conclusion of the annual general meeting of the Company to be held in 2022. Mr. Simon Rowlands will be represented on the Board of directors by Africa Platform Capital LLP, which is appointed as a director;
·      To appoint Ms. Tatiana Lukina as an independent non-executive director of the Company with an annual gross remuneration of RUR 944 000, to hold such office until the conclusion of the annual general meeting of the Company to be held in 2022;
·      To appoint Mr. Vitaly Ustimenko as a non-executive director of the Company with an annual gross remuneration of RUR 944 000, to hold such office until the conclusion of the annual general meeting of the Company to be held in 2022; 
·      To appoint Mr. Vladimir Mekler as a non-executive director of the Company and the Chairman of the Board of Directors without remuneration, to hold the office until the conclusion of the annual general meeting of the Company to be held in 2024;
·      To appoint Mr. Mark Kurtser as an executive director of the Company without remuneration, to hold the office until the conclusion of the annual general meeting of the Company to be held in 2024;
·      To appoint Mr. Kirill Dmitriev as a non-executive director of the Company without remuneration, to hold the office until the conclusion of the annual general meeting of the Company to be held in 2024;
·      To approve the payment of a dividend, out of the profits made during the year 2020, in the amount of RUR 19 per share, (in addition to the dividends in the amount of RUB 9,8 per share paid as interim dividends for H1 2020) as proposed in the directors' report be and is hereby approved. Subject to shareholders' approval of the dividend at the annual general meeting of shareholders of the Company, the dividend record date is set as May 05, 2021. The Global Depository Receipts will be marked as ex-dividend on May 04, 2021. The pay date for GDR holders is set as May 25, 2021. The payment shall be made in USD at the rate of the Central Bank of Russia on 19 March, 2021.
The Minutes of the AGM are available for viewing at the registered office of the Company at office 9-2, bld. 3, 6 Azovskaya str.,  Moscow, Russian Federation and will be available at the National Storage Mechanism of the UK Listing Authority, located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism, in due course.  
This announcement contains inside information.
For further information please contact:




Investors


Media




            
Dmitry Yakushkin 
MD Medical Group Investments Plc
Tel: +7 495 139 87 40, ext. 16329

d.yakushkin@mcclinics.ru


EM



Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
MDMG@em-comms.com




About MD Medical Group
 
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok, Krasnodar and Rostov-on-Don.
The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
Since November 9, 2020 the Company's GDRs are traded also on the Moscow Exchange. Quotation is done in Russian Rubles.
Forward-Looking Statements:
This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
 
 
 
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
RAGIJMATMTATMMB